Page last updated: 2024-08-23

alovudine and plx 4720

alovudine has been researched along with plx 4720 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coffey, RJ; Fu, A; Manning, HC; McKinley, ET; Saleh, SA; Smith, RA; Uddin, MI; Washington, MK; Zhao, P	1

Other Studies

1 other study(ies) available for alovudine and plx 4720

Article	Year
3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:3 Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Drug Resistance, Neoplasm; Fluorine Radioisotopes; Humans; Indoles; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Targeted Therapy; Mutant Proteins; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Sulfonamides; Xenograft Model Antitumor Assays	2013

Article

Year

3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:3

Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Drug Resistance, Neoplasm; Fluorine Radioisotopes; Humans; Indoles; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Targeted Therapy; Mutant Proteins; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Sulfonamides; Xenograft Model Antitumor Assays

2013